Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated speciality pharmaceutical company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, we’re rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines.
Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigour, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies.